Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Category

Sub-category

Conference

Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC

Prof Scott Tagawa - Weill Cornell Medicine, New York City, USA

Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC ( Prof Scott Tagawa - Weill Cornell Medicine, New York City, USA )

ASCO GU 2023: Latest real world data in prostate cancer

Prof Phil Cornford and Prof Laura-Maria Krabbe

ASCO GU 2023: Latest real world data in prostate cancer ( Prof Phil Cornford and Prof Laura-Maria Krabbe )

Erdafitinib demonstrates efficacy in intermediate-risk non–muscle-invasive...

Prof Siamak Daneshmand - University of Southern California, Los Angeles, USA

Erdafitinib demonstrates efficacy in intermediate-risk non–muscle-invasive bladder cancer with FGFR alterations ( Prof Siamak Daneshmand - University of Southern California, Los Angeles, USA )

Cell-free utDNA may predict transurethral resection of bladder tumour pathology...

Dr Kyle Rose - Moffitt Cancer Center, Florida, USA

Cell-free utDNA may predict transurethral resection of bladder tumour pathology in non–muscle invasive bladder cancer ( Dr Kyle Rose - Moffitt Cancer Center, Florida, USA )

IMvigor130 study: Final OS analysis of atezo + plt/gem vs placebo + plt/gem...

Prof Aristotelis Bamias - University of Athens, Athens, Greece

IMvigor130 study: Final OS analysis of atezo + plt/gem vs placebo + plt/gem used to treat mUC ( Prof Aristotelis Bamias - University of Athens, Athens, Greece )

Treatment sequencing for patients with mCRPC

Prof Axel Merseburger and Prof Stéphane Oudard

Treatment sequencing for patients with mCRPC ( Prof Axel Merseburger and Prof Stéphane Oudard )

Hypofractionated high dose intensity modulated radiotherapy non-inferior for...

Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK

$Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer ( Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK )$

JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for...

Dr Srikala Sridhar - Princess Margaret Cancer Centre, Ontario, Canada

JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for advanced urothelial carcinoma ( Dr Srikala Sridhar - Princess Margaret Cancer Centre, Ontario, Canada )

Stereotactic body radiotherapy compared with surgery for localised prostate...

Dr Nicholas John van As - The Royal Marsden NHS Foundation Trust, London, UK

Stereotactic body radiotherapy compared with surgery for localised prostate cancer ( Dr Nicholas John van As - The Royal Marsden NHS Foundation Trust, London, UK )

Changes in planned disease management after PET/CT in men with biochemically...

Dr Frédéric Pouliot - Université Laval, Quebec, Canada

Changes in planned disease management after PET/CT in men with biochemically recurrent prostate cancer and low PSA levels ( Dr Frédéric Pouliot - Université Laval, Quebec, Canada )

Abiraterone acetate/prednisone + apalutimide and ADT with post-op SRT may...

Prof Paul L Nguyen - Dana-Farber Cancer Institute, Boston, USA

Abiraterone acetate/prednisone + apalutimide and ADT with post-op SRT may improve PFS and MFS after prostatectomy ( Prof Paul L Nguyen - Dana-Farber Cancer Institute, Boston, USA )

Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous...

Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA

Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous cell carcinoma ( Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer